Bison Capital Acquisition Corp. (BCAC)

10.59 +0.04 (+0.379%)

IEX Real-Time Price

April 18, 2019 EST.

NASDAQ Capital Market : Industrials

Prev Close 10.55

Price Open 10.59

Volume: 300

Avg Volume: 6,564

Market Cap: 84.5M

P/E Ratio -

52 Wk Range 9.835-11



BCAC Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-10-15
2.43M
150,735
7.31
6.20%

2018-09-28
2.43M
4,946
0.20
0.20%

2018-09-14
2.43M
403
0.04
0.02%

2018-08-31
2.43M
405
0.18
0.02%




News

Xynomic Pharmaceuticals, Inc. Will Present at ASCO 2019 Annual Meeting, Will Sponsor an EU Investigator Meeting for Potentially Pivotal Kidney Cancer Trial, and Appoints Interim Chief Accounting Officer (2019-03-20 13:45 PR Newswire)

RALEIGH, N.C. and SHANGHAI , March 20, 2019 /PRNewswire/ --Xynomic Pharmaceuticals, Inc. ("Xynomic"), a clinical stage US-China oncology drug development company, and Bison Capital Acquisition Corporation (Nasdaq: BCAC), jointly announced that Xynomic and its collaborators will pr…

 


Statistics

Shares Outstanding: 7.98M

Top 15 Institution Percent: 65.40

Price To Sales: N/A

Price To Book: 1.35

Revenue: N/A

Gross Profit: N/A

Cash: N/A

Debt: N/A

Return On Assets: -1.17

Return On Equity: -1.18

Profit Margin: N/A

Price History

Beta: 0.01

50-day Moving Avg: 10.52

200-day Moving Avg: 10.32

YTD Change: 1.73

5-day Change: N/A

1-month Change: 0.86

3-month Change: 1.27

6-month Change: 2.82

1-year Change: 6.11

Revenue Per Share: 0.00

Revenue Per Employee: 0.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Bison Capital Acquisition Corp.

Exchange: NASDAQ Capital Market

Industry: Conglomerates

Sector: Industrials

Website:

Bison Capital Acquisition Corp is a newly organized blank check company.